Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
5.99
-0.18 (-2.92%)
Aug 8, 2025, 4:00 PM - Market closed

Paramount Global Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
26.7918.5319.1319.995.74-
Cash & Short-Term Investments
26.7918.5319.1319.995.74-
Cash Growth
47.90%-3.10%-4.34%248.19%--
Other Current Assets
0.210.070.060.410.09-
Total Current Assets
27.0118.6119.1920.415.83-
Long-Term Deferred Charges
----0.82-
Total Assets
27.0118.6119.1920.416.66-
Accounts Payable
4.982.52.772.911.060.01
Accrued Expenses
5.086.44.212.830.54-
Other Current Liabilities
0.08--0.450.82-
Total Current Liabilities
10.148.896.986.192.420.01
Total Liabilities
10.148.896.986.192.420.01
Additional Paid-In Capital
101.7882.9666.4546.21.89-
Retained Earnings
-84.91-73.25-54.25-31.99-12.9-0.01
Total Common Equity
16.879.7112.214.22-11.01-0.01
Shareholders' Equity
16.879.7112.214.224.24-0.01
Total Liabilities & Equity
27.0118.6119.1920.416.66-
Net Cash (Debt)
26.7918.5319.1319.995.74-
Net Cash Growth
47.90%-3.10%-4.34%248.19%--
Net Cash Per Share
1.401.081.231.581.35-
Filing Date Shares Outstanding
25.4623.3917.7714.7512.723.9
Total Common Shares Outstanding
23.8819.517.4214.644.513.9
Working Capital
16.879.7112.214.223.41-0.01
Book Value Per Share
0.710.500.700.97-2.44-0.00
Tangible Book Value
16.879.7112.214.22-11.01-0.01
Tangible Book Value Per Share
0.710.500.700.97-2.44-0.00
Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q